Citations

Clear

873 citation(s) found for "Carlson, EE".

Abstract 4367166: A Multicenter Study of Detection of Pulmonary Hypertension Based on Point-of-Care 12- Lead ECG Data
Agarwal, Richa , Wieczorek, Mikolaj A. , Hackett, Sarah, Carlson, Katherine , Klugherz, Paul, Wagner, Tyler , DuBrock, Hilary M. , Johnson, Patrick W. , Frantz, Robert P. , Strom, Jordan B. , Waks, Jonathan W. , Hemnes, Anna R. , Steinberg, Benjamin A. , Pandey, Ambarish , Hackett, Sarah, Alger, Heather M. , Carter, Rickey E. , Wagner, Tyler

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4367166 Get It

Background: Pulmonary hypertension (PH) is a life-threatening disease affecting up to 1% of the global population. Diagnosis can be challenging and is often delayed due to the need for advanced imaging and invasive procedures. The use of artificial intelligence applied to ECGs (ECG-AI) has been shown to detect subtle patterns in voltage-time data and may be a valuable tool for the early detection of PH. Hypothesis and Purpose: To evaluate the performance of a previously trained, ECG-AI algorithm to detect PH (ECG-AI PH) using real-world data (RWD) collected in a multicenter, validation study. A joint primary hypothesis required sensitivity (Sn), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) to exceed the null values of 76%, 70%, 10% and 90%. Study Design and Methods: This retrospective validation study was conducted at 5 geographically diverse U.S. health systems. Adult subjects were eligible for inclusion if they had a 12-lead ECG paired with an echocardiogram (Echo) in which tricuspid regurgitation velocity (TRV) was recorded, following presentation with dyspnea. Patients were classified according to echocardiographic criteria as either PH (PH+, TRV >3.4 m/s) or controls (PH-, TRV ≤2.8 m/s) to simulate the real-world use of ECG-AI, where a positive result could lead to a follow-up Echo. The study database was locked before processing the digital ECGs with ECG-AI PH. Performance was also estimated in a subset of subjects that later had a right heart catheterization using mPAP ≥ 20mmHg as the definition of PH. Results: A total of 14281 subjects (53% female, 63% aged 50+ years) met the inclusion criteria, including 3019 PH+ cases and 11262 PH- controls (Figure). Sn and Sp were 84.0% (95% CI: 82.6%, 85.3%) and 71.7% (95% CI: 70.9%, 72.6%), respectively. The positive and negative predictive values were 18.9% (95% CI: 18.4%, 19.4%) and 98.3% (95% CI: 98.1%, 98.4%), respectively, at 7.3% prevalence. Each endpoint met pre-defined performance criteria. In the subset of 1683 subjects with a follow up RHC, performance remained robust (Sn 85% (1155/1358); Sp 46% (151/325)). Conclusion: While ECG-AI PH was first developed as an investigational tool to detect PH, continued development as software as a medical device for clinical use demonstrated that the algorithm retained strong performance to detect PH in diverse, non-overlapping clinical settings and patient populations.
Abstract 4367109: Evaluation of a Novel Artificial Intelligence Electrocardiogram Tool for Early Identification of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Carlson, Katherine , Wagner, Tyler , DuBrock, Hilary M. , Alger, Heather M. , Frantz, Robert P.

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4367109 Get It

Introduction: Pulmonary hypertension (PH) is a life-threatening, progressive disease with non-specific symptoms, often leading to delayed diagnosis. Early identification of World Health Organization Group 1 (Pulmonary Arterial Hypertension, PAH) and Group 4 (Chronic Thromboembolic Pulmonary Hypertension, CTEPH) is essential, as effective therapies can improve outcomes. Hypothesis: An electrocardiogram-based AI algorithm for PH detection (ECG-AI PH) may enable earlier diagnosis and reduce healthcare utilization, including hospitalizations and procedures. Methods: Retrospective analysis used a de-identified data platform of >7M clinical records from a multistate integrated health system. Adult precapillary PH patients (mPAP >20 mmHg, PVR >2 WU, PCWP ≤15 mmHg) were identified as PAH or CTEPH based on ICD codes, use of approved therapies, or surgical interventions (for CTEPH) between 2002 and 2024. ECG-AI PH was applied to ECGs within 30 days of diagnostic right heart catheterization, using a 5:1 randomly sampled PH-negative control cohort. Training set patients were excluded. Clinical event frequency was compared between two intervals: from first possible PH symptom (dyspnea, syncope, chest pain, fatigue, lower limb swelling) to diagnosis, and from symptom onset to first positive ECG-AI PH prediction. Results: A total of 1882 PAH and 359 CTEPH patients met inclusion criteria. Of these, 1340 PAH and 258 CTEPH patients had symptom codes prior to diagnosis. Both groups showed prolonged intervals from symptom onset to diagnosis, with multiple diagnostic procedures and hospitalizations (Figure). ECG-AI PH performance evaluation on the test set included 647 PAH and 152 CTEPH patients. ECG-AI PH achieved AUCs of 0.90 and 0.89 for PAH and CTEPH, sensitivities of 80.3% and 76.8%, and specificities of 83.4% and 82.4%. Among those tested, 576 PAH and 95 CTEPH patients had a positive ECG-AI PH prediction after symptom onset but before diagnosis. Compared to the current patient journey, the interval between initial symptoms and a positive output from ECG-AI PH was shorter and had fewer diagnostic tests/visits. Conclusion: ECG-AI PH demonstrated strong performance in detecting PAH and CTEPH. It may reduce diagnostic delays, support earlier PH-focused screening (e.g., echocardiograms evaluating the right heart), enable earlier intervention, and reduce pre-diagnosis healthcare burden, benefitting both patient outcomes and healthcare system efficiency.
Indomethacin Fails to Increase Intestinal Permeability in Healthy Volunteers
Camilleri, Michael , Busciglio, Irene, Carlson, Paula, Lupianez‐Merly, Camille , Yang, David Yi , Ryks, Michael, Ferber, Monique, Houamel, Dounia, Perot, Stéphanie, Montestruc, François , Dilmaghani, Saam , Lupianez-Merly, Camille, Yang, David Y.

Mayo Clinic

Clinical and Translational Gastroenterology | October 28, 2025 | Volume: 17 | Issue: 1 | Pages: e00944

10.14309/ctg.0000000000000944 | PMID 41147830 Get It

INTRODUCTION: Indomethacin is often used experimentally to induce intestinal hyperpermeability, enabling evaluation of interventions targeting barrier function. METHODS: We conducted a randomized, double-blind, placebo-controlled study (NCT05538247) in healthy volunteers to assess whether a supplement could mitigate indomethacin-induced hyperpermeability. Participants received 150 mg/d of indomethacin for 6 days, either before or during placebo/supplement administration. Permeability was measured using 13 C-mannitol and lactulose urinary excretion. RESULTS: Contrary to expectations, indomethacin failed to increase 13 C-mannitol excretion in either group. No meaningful elevations in serum (zonulin, claudins) or fecal (calprotectin) biomarkers were observed. DISCUSSION: Our findings suggest that the expected increase in intestinal permeability after indomethacin administration may not be consistently observed in healthy volunteers. These results highlight the need to carefully consider the reproducibility and sensitivity of this model in future clinical studies aiming to investigate gut barrier function.
Modified Clavien-Dindo Classification for Adverse Events in Otolaryngology–Head and Neck Surgery
Hidalgo, C. , Martin, Eliot J., Eyassu, Daniel G. , Hernandez-Herrera, Gabriel A. , Jenkins, Sarah M. , Chweya, Cynthia M. , Sankar, George B., Carlson, Matthew L. , Moore, Eric J. , Wiedermann, Joshua P. , Abel, Kathryn M. Van , Hidalgo, Cecelia M, Bayan, Semirra L. , Van Abel, Kathryn M , Hernandez Herrera, Gabriel A , Hamilton, Grant

Mayo Clinic

JAMA Network Open | October 27, 2025 | Volume: 8 | Issue: 10 | Pages: e2539761

10.1001/jamanetworkopen.2025.39761 | PMID 41143791 Get It

Importance Adverse events in otolaryngology–head and neck surgery (OHNS) are inconsistently reported. The Clavien-Dindo Classification has been modified and validated in several surgical subspecialties but has yet to be validated in OHNS. Objective To create and validate a modified Clavien-Dindo Classification for OHNS that reflects the severity and duration of harm for complications experienced by patients undergoing OHNS. Design, Setting, and Participants This is a multicenter survey study of subject matter experts (SMEs) from OHNS subspecialties from academic institutions within the US. A literature review identified publications reporting surgical complications in OHNS in the English language between January 2019 and April 2020. Complications were summarized and used to inform a modified Clavien-Dindo Classification. Feedback from internal SMEs was incorporated. Thirty-five clinical vignettes were created, and an electronic survey was sent to SMEs at outside institutions. Each SME was randomly assigned to 1 of 4 groups to evaluate 8 to 9 vignettes. The survey was conducted in September 2023, and data were analyzed from February to May 2024. Exposure Participation in the electronic survey. Main Outcomes and Measures Vignette scores were assessed and the Comprehensive Complication Index (CCI) calculator was used to assess cumulative morbidity. The scale is based on the grading by the Clavien-Dindo Classification and reflects overall morbidity on a scale from 0 (no complication) to 100 (death). Variability of the CCIs between reviewers, the primary outcome, was summarized with the SD. The percentage of reviewers with a high (≥26.2) or low (<26.2) CCI within a vignette was reported. Reliability was summarized using Krippendorff α. Results Of 106 SMEs, 43 (response rate, 40.6%) completed at least 1 vignette. Eighteen of 35 vignettes (51.4%; 95% CI, 34.9%-68.0%) had unanimous high CCI, and 8 of 35 vignettes (22.9%; 95% CI, 8.9%-36.8%) had unanimous low CCI (overall categorical agreement, 74.3%; 95% CI, 59.8%-88.8%). On average, the Krippendorff α was 0.74, indicating moderate reliability. A total of 21 850 OHNS complications were reviewed and categorized as surgical or medical with 12 including subcategorization for specificity. Each category was then assigned a modified OHNS Clavien Dindo classification grade. Conclusions and Relevance In this survey study of OHNS experts, a modified OHNS Clavien-Dindo Classification was developed and validated using case vignettes. The modified Clavien-Dindo Classification provided a granular subcategorization for each complication category and grade, duration of harm, and an overall summary complication score (CCI). Results suggest the modified OHNS Clavien-Dindo Classification reliably differentiated between high-grade and low-grade OHNS complications and could be utilized for assessing surgical outcomes.
Abstract B090: Radiation-induced oral mucositis to rapidly determine effective radiosensitizing dosing regimens for ATM and DNAPK inhibitors
Le, Jiayan, Ott, Lauren L. , Hu, Zeng , Carlson, Brett L. , Abraham, Jessica L., Decker, Paul A. , Kosel, Matthew , Eckel‐Passow, Jeanette E. , Elmquist, William F. , Zhong, Wei , Burgenske, Danielle M. , Garcia, D. , Zhang, Wenjuan , Rathi, Sneha , Bakken, Katrina K. , Mladek, Ann C. , Decker, Paul A. , Zhong, Wei, Sarkaria, Jann N.

Mayo Clinic

Molecular Cancer Therapeutics | October 22, 2025 | Volume: 24 | Issue: 10_Supplement | Pages: B090-B090

10.1158/1535-7163.targ-25-b090 Get It

Abstract Failure to repair radiation (RT)-induced DNA damage results in cell lethality, and combined treatment with DNA repair inhibitors can markedly enhance tumor control achieved with radiation. These inhibitors also can potentiate acute RT toxicities by suppressing DNA repair. Capitalizing on this normal tissue radiosensitizing effect, we determined effective radiosensitizing dosing regimens in mice for the ATM inhibitor WSD0628 and the DNAPK inhibitor WNC0901 in mice. Drugs were administered via oral gavage prior to each RT dose, and RT was delivered using an anterior/posterior 225 kVp beam. In an initial iteration of this model, various combinations of WSD0628 and RT were administered to cohorts of mice (n=5/group) and body weight was followed for 2 weeks. The resulting data were modeled to define the total dose of radiation estimated to cause 50% of mice to lose >20% body weight (D50). There was an inverse relationship between the WSD0628 and D50 doses: 0 mg/kg WSD0628/24.0 Gy (95% confidence interval (CI) 24.5–24.7); 0.25 mg/kg/19.2 Gy (95% CI 16.7–21.8); 1 mg/kg/13.7 Gy (95% CI 13.2–14.2); 2.5 mg/kg/11.0 Gy (95% CI 10.5–11.5); 5 mg/kg/11.3 Gy (95% CI 6.7–15.9) and 7.5 mg/kg/7.8 Gy (95% CI 7.8–7.9). Histological review of tongues from animals treated with 15 Gy RT (5Gy x 3) + 7.5 mg/kg WSD0628 demonstrated epithelial denudation and acute inflammation consistent with oral mucositis, while these features were not seen with the same dose as RT alone. Similar WSD0628 doses were evaluated in combination with 8 Gy supratentorial RT (via lateral beams) in orthotopic GBM43 PDX tumors. By treatment arm, the median time to a moribund state was: sham (29 days (d)), RT (39d), 1 mg/kg (42d), 2.5 mg/kg (49d), 5 mg/kg (65d), and 10 mg/kg (123d, overall p<0.0001). A second mucositis model was used for evaluation of WNC0901. Cohorts of 5 mice/group were treated with a set dose of RT (4Gy x 3) to the oral cavity alone and in combination with various doses of WNC0901, and the fraction of mice with >20% weight loss within 2 weeks was determined. The results of this study are as follows: placebo (0 of 5 mice with >20% weight loss); 15 mg/kg (3 of 5 mice); 25, 50, or 100 mg/kg (5 of 5 mice). Based on these data, we defined 25 mg/kg WNC0901 as the minimally effective dose and predicted that 50 mg/kg would provide robust radiosensitization. Consistent with this prediction, co-treatment of B16 melanoma flank tumor xenografts with RT (8Gy x 1) and WNC0901 (50 mg/kg) more than doubled the median tumor control duration (median 42 [range 24-45] days; time from implantation for tumor to exceed 1500 mm3) as compared to RT alone (24 [13-30] days) or sham treatment (17 [13-17] days; overall p<0.0001). This study describes how a radiation-induced oral mucositis model can be used to identify effective radiosensitizing regimens faster and with fewer resources than relying on tumor control studies alone. Citation Format: Danielle Burgenske, Darwin Garcia, Jiayan Le, Wenjuan Zhang, Sneha Rathi, Katrina K. Bakken, Lauren L. Ott, Zeng Hu, Brett L. Carlson, Ann Mladek, Jessica L. Abraham, Paul A. Decker, Matthew L . Kosel, Jeanette E. Eckel-Passow, William F. Elmquist, Wei Zhong, Jann N. Sarkaria. Radiation-induced oral mucositis to rapidly determine effective radiosensitizing dosing regimens for ATM and DNAPK inhibitors [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; 2025 Oct 22-26; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2025;24(10 Suppl):Abstract nr B090.
Radiosurgery for Facial Nerve Schwannoma: A Systematic Review
Khandalavala, Karl R. , Dornhoffer, James R. , Carlson, Matthew L. , Olson, Brennan

Mayo Clinic

Otology & Neurotology | October 17, 2025 | Volume: 46 | Issue: 10 | Pages: 1324-1329

10.1097/mao.0000000000004652 | PMID 41102902 Get It

Objective: To systematically review the existent literature on radiosurgery for treatment of sporadic facial nerve schwannomas (FNS). Databases reviewed: PubMed, SCOPUS, EMBASE, and Web of Science databases. Methods: Systematic review was performed per PRISMA criteria of studies published from 1990 through 2024 on patients diagnosed with sporadic FNS who were treated with radiosurgery. Outcomes included change in facial nerve function, change in hearing class, and radiosurgical treatment failure defined by need for reintervention. Study quality was assessed using the LEGENDS rubric for mixed modality studies. Results: In total, 35 studies encompassing 364 patients were included for data abstraction. Gamma Knife was the most common modality reported. Longitudinal patient-level data on facial nerve function were available for 101 patients, with 8% of patients experiencing worsening facial nerve function and 92% of patients having either stable nerve function or improvement in facial nerve function following treatment over a median follow-up of 36 months. Longitudinal patient-level hearing data were available for 53 patients, including 35 patients with serviceable hearing (AAO-HNS class A or B) at baseline; only 2 patients developed nonserviceable hearing (AAO-HNS class C or D) following treatment over a median follow-up of 36 months. Clinical tumor control data were available for 295 patients, of whom 11 required salvage treatment over a mean follow-up of 49 months. Conclusions: This systematic review demonstrates a relatively low risk of worsening facial nerve function and a high rate of clinical tumor control following radiosurgery for sporadic FNS.
Practice Patterns and Outcomes of Dacryocystorhinostomy for Secondary Nasolacrimal Duct Obstruction
Farrell, Lily , Kopinski, Piotr K., Hassoun, Mohamad Rani , Graves, Jeffrey P., Stokken, Janalee K. , Tooley, Andrea A. , Farrell, Lily C , Carlson, Matthew L , Bradley, Elizabeth A. , Wagner, Lilly H.

Mayo Clinic

American Journal of Rhinology & Allergy | October 8, 2025 | Volume: 40 | Issue: 2 | Pages: 112-117

10.1177/19458924251386210 | PMID 41060922 Get It

Background Sinonasal pathology, such as chronic inflammatory disease or neoplasm, can cause secondary nasolacrimal duct obstruction (sNLDO). There is a paucity of data on dacryocystorhinostomy (DCR) techniques and outcomes for NLDO secondary to known sinonasal pathologies. Objective To describe case characteristics, management, and surgical outcomes of sNLDO at a tertiary academic center. Methods Charts of DCR cases with at least 3 months follow-up done at a single institution over a 5-year period (2018-2022) were reviewed. Patient and surgical characteristics were recorded and compared between secondary and primary NLDO groups. The primary outcome was early functional success of DCR, assessed by improvement or resolution of epiphora at 3 months. Results A total of 236 cases were included. Of those, 79 (33.5%) were classified as secondary NLDO associated with sinonasal pathology. Reasons for sNLDO were sinonasal cancer (46.8%), chronic inflammatory disease (24.1%), trauma (16.5%), or prior head and neck radiation (31.6%). When comparing primary acquired NLDO to sNLDO cases, DCR for sNLDO was more likely to be performed endoscopically (68.4% vs 31.8%, P < .01), by a multidisciplinary team of rhinologist and oculoplastic surgeon (70.9% vs 8.3%, P < .01), and required bilateral surgery (36.7% vs 5.7%, P < .01). The overall functional success rate was 79.7% for sNLDO compared to 87.9% for primary acquired NLDO ( P < .01). Revision surgery for sNLDO, history of sinonasal malignancy, and radiation were associated with lower functional success rates (66.7%, 70.3%, and 68.0%, respectively). Canalicular pathology was more common in sNLDO cases (29.0% vs 8.3%, P < .01). Conclusions Secondary NLDO was more commonly managed with an endoscopic approach by a multidisciplinary team. Revisions for sNLDO, as well as cases with a history of sinonasal malignancy and radiation, had a markedly lower success rate, and sNLDO was frequently associated with canalicular obstruction. These findings may facilitate surgical planning and patient counseling.
Abstract Wed136: Integration of Mechanistic Fontan Circulatory Models with Interpretable Machine Learning Classifiers
Schenk, Noah A. , Egbe, Alexander , Beard, Daniel , Carlson, Brian E.

Mayo Clinic

Circulation Research | October 8, 2025 | Volume: 137 | Issue: Suppl_1 | Pages: No page available

10.1161/res.137.suppl_1.wed136 Get It

Introduction/Background: Despite numerous medical advances, 30% of patients with Fontan circulation require heart transplantation by 21. Current risk stratification relies on clinical metrics that lack strong correlations to patient outcomes, leading to a high waitlist mortality. Hypothesis: Integration of physics-based hemodynamic modeling with interpretable machine learning will improve prediction of patient outcomes (listing for heart transplant and/or cardiac death) by quantifying physiologic mechanisms inaccessible through clinical measures alone. Goals/Aims: 1. Develop a lumped-parameter mechanistic model (LPMM) of Fontan circulation 2. Identify patient clusters and predictors of patient outcomes 3. Validate model-informed classifiers against clinical-only approaches Methods/Approach: A LPMM incorporating ventricular sarcomere mechanics, atrial hemodynamics, and vascular viscoelastic effects was optimized to cardiac catheterization and echocardiography data from 51 patients (age 25±8 years). Thirty-eight parameters (ventricular inotropy, atrial stiffness, pulmonary elastance, etc.) were calibrated via surrogate optimization, minimizing least-squares error versus 11 clinical targets. Partial least-squares regression with leave-one-out cross-validation compared clinical-only versus model-informed classifiers of outcomes. Results/Data: The LPMM achieved 2% mean error across hemodynamic targets, with CVP and pulmonary pressures matching clinical measurements within 1%. Model-derived minimum atrial pressure (4.46±1.78 vs 2.68±0.87 mmHg, p<0.05) outperformed all clinical variables in discriminating patient outcomes. Integration of LPMM parameters increased AUROC from 0.67 to 0.78 for patient outcome prediction. Conclusions: Physics-based modeling identifies ventricular passive stiffness, atrial end-diastolic volume, and minimum atrial pressure, along with patient age (a clinical value) as critical determinants of Fontan failure. Combined mechanistic-machine learning approaches enable phenotype-specific risk stratification, supporting earlier referral for advanced therapies. This methodology establishes a framework for precision management of complex congenital circulations.
The Protein Tyrosine Phosphatase 1B Modulates the Activation of Yes-Associated Protein and Sensitizes to Cytotoxic Chemotherapy in Preclinical Models of Cholangiocarcinoma
Watkins, Ryan , Tomlinson, Jennifer L. , Buckarma, EeeLN H. , Carlson, Danielle M. , Werneburg, Nathan W., O’Brien, Daniel R. , Smoot, Rory L. , Watkins, Ryan D, Kuipers, Hendrien , O'Brien, Daniel R, Smoot, Rory L , Tomlinson, Jennifer , Carlson, Danielle Marie , Wang, Chen

Mayo Clinic

Cells | October 8, 2025 | Volume: 14 | Issue: 19 | Pages: 1560

10.3390/cells14191560 | PMID 41090788 Get It

Lacking effective therapeutics, cholangiocarcinoma (CCA) remains a deadly malignancy of the biliary tract. The Hippo pathway effector protein Yes-associated protein (YAP) is implicated in CCA pathogenesis and chemotherapeutic resistance; however, the oncogenic mechanisms underlying YAP regulation remain incompletely understood. An enhanced understanding of YAP and its role in CCA may uncover novel therapeutic targets and better define resistance pathways. Human CCA cells and murine syngeneic CCA models were utilized to explore the molecular relationship of YAP and protein tyrosine phosphatase 1B (PTP1B). Previous work in CCA has demonstrated that YAP interacts with multiple protein tyrosine phosphatases, including SHP2 and PTP1B. We observed that PTP1B pharmacologic inhibition was associated with increased cell proliferation and YAP target gene expression, while genetically enforced overexpression of PTP1B was associated with a decrease in YAP activation. Treatment of CCA cells in vitro and syngeneic, orthotopically implanted CCA murine tumors in vivo with standard cytotoxic chemotherapy, gemcitabine/cisplatin, had enhanced efficacy in the setting of PTP1B overexpression. These findings demonstrate that pYAPY357 can be modulated through protein tyrosine 1B phosphatase activity, and reducing pYAPY357 through enhanced phosphatase levels can sensitize CCA to chemotherapy.
Using Surgical Navigation to Capture Objective Metrics During Endoscopic Sinus Surgery: A Proof-of-Concept Study
Fearington, Forrest W. , Jabbour, Christopher , Stokken, Janalee K. , Pinheiro Neto, Carlos D, Carlson, Matthew L , Pinheiro‐Neto, Carlos

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | October 6, 2025 | Volume: 135 | Issue: 2 | Pages: 140-145

10.1177/00034894251379919 | PMID 41051162 Get It

Background: Evaluation of otolaryngology resident technical performance has historically relied on subjective perioperative feedback. Despite various assessment tools attempting to provide consistent surgical skill evaluations, current methods remain inherently subjective. Aim: This proof-of-concept pilot study aimed to assess if a 3-dimensional surgical navigation system could capture objective surgical data during endoscopic sinus surgery (ESS). A secondary aim was to analyze if there were any differences between novice and practiced trainees. Methods: Otolaryngology residents performed supervised ESS on patients while their instrument (microdebrider, suction) motion was recorded using a TruDi ® Navigation System. Prior to the surgery, surgical landmarks were defined with sensory beacons in the navigation system using the patient’s preoperative computed tomography (CT) scan. Metrics included time to reach beacons, number of alerts at each beacon, and instrument speed. Results: Fifteen otolaryngology residents performed 87 ESS. The navigation system successfully obtained “time to reach sinus X” data for 64% of sinuses/ case, velocity data in 93% of cases, and number of beacon “alerts” per minute in 93% of cases. We found a significant difference between PGY 3 residents and PGY 4/PGY5 residents in the number of sphenoid sinus alerts per minute ( P = .01) and the percentage of cases in which the resident accessed the maxillary sinus via the natural os ( P < .001). Impact: This study demonstrates the feasibility of collecting objective, navigation-based intraoperative metrics during live surgery and is a first step toward building a comprehensive objective assessment tool in ESS. We hope this report encourages further research into this technology’s application in objective resident skill assessment and correlation with concurrent faculty assessments.